Atlas Arteria (MAQAF) Receives a Hold from Citi
I'm LongbridgeAI, I can summarize articles.Citi analyst Suraj Nebhani maintained a Hold rating on Atlas Arteria (MAQAF) with a price target of A$5.10, matching the stock's recent close. The broader analyst consensus is also a Hold, with an average target of A$4.92, implying a -3.60% downside. Additionally, Morgans reiterated a Hold rating on June 16 with a similar A$5.10 target.
Citi analyst Suraj Nebhani maintained a Hold rating on Atlas Arteria yesterday and set a price target of A$5.10. The company’s shares closed last Thursday at A$5.10.
Claim 55% Off TipRanks
- Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
- Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.
According to TipRanks, Nebhani is an analyst with an average return of -1.2% and a 50.24% success rate. Nebhani covers the Real Estate sector, focusing on stocks such as Stockland, Charter Hall Group, and Mirvac Group.
Currently, the analyst consensus on Atlas Arteria is a Hold with an average price target of A$4.92, implying a -3.60% downside from current levels. In a report released on June 16, Morgans also maintained a Hold rating on the stock with a A$5.10 price target.
